Argentinian Massive Protest against Government Crackdown on Cannabis Registration Organization

Regulations by 2FIRSTS.ai
Apr.29.2024
Argentinian Massive Protest against Government Crackdown on Cannabis Registration Organization
Argentina to hold massive cannabis march on May 4 in response to government crackdown on cannabis registration organization.

According to Argentine media outlet 0223, on April 28th, as the debate surrounding marijuana use becomes a nationwide focal point, Argentina will hold a large-scale marijuana march.

 

This protest was aimed at the Argentinian government's early review of the marijuana program registration organization (Reprocann). To this end, marijuana protests will be held nationwide on May 4, with La Plata as the central location.

 

The parade organizing committee stated that:

 

The recent statement from Presidential Spokesperson Manuel Adorni confirms long-standing concerns that the new government measures will deprive individuals who use marijuana for medical treatment of their health rights. The government's position is aimed at attacking the Reprocann registry, which is responsible for controlling the production of medical marijuana in our country.

 

Despite the passing of the Medical Cannabis Act seven years ago and the Industrial Cannabis Act two years ago, the cannabis community continues to grow and expand. From scientific research on the use and properties of cannabis, to supplying the medical system and industrial production, to the treatment of various illnesses, the entire cannabis industry is increasingly becoming a pillar of progress.

 

Javier Milei's government-led policies threaten the basic right to health of the public and regress to the failed "war on drugs" model. This approach will only harm the most vulnerable populations, strengthening drug traffickers and criminal networks. Therefore, marijuana advocates are calling on the public to maintain the current regulatory framework for marijuana laws.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
At the inaugural AFN, Dr. Rohan Sequeira and Dr. Alex Wodak emphasized that THR offers a science-based approach to reduce smoking-related harm—not merely as an alternative to cessation. They urged policymakers across Asia to reassess tobacco control and include non-combustible products in public health strategies. This article outlines the scientific foundation of THR, its regional challenges, and growth momentum.2Firsts provided in-depth coverage of the forum.
Sep.09
Newport, UK Seizes £6.5 Million Worth of Illegal Goods, Targeting E-Cigarettes and Counterfeit Products
Newport, UK Seizes £6.5 Million Worth of Illegal Goods, Targeting E-Cigarettes and Counterfeit Products
From 2024 to 2025, Newport Trading Standards seized £6.5 million worth of illegal tobacco, e-cigarettes, and counterfeit goods in 41 raids, including 300,000 cigarettes and 12,400 e-cigarette items. The crackdown led to a year-on-year drop in tobacco sales to minors.
Jul.21 by 2FIRSTS.ai
Product | Brands Like Off-Stamp and SKE Launch Clear-Tank E-Cigarettes in UK and US Markets
Product | Brands Like Off-Stamp and SKE Launch Clear-Tank E-Cigarettes in UK and US Markets
Several new e-cigarette products featuring clear-tank designs have recently entered the market, including the Off-Stamp X Cube Crystal Cube 35K in the U.S. and the SKE Crystal Edge X in the UK. These models offer increased puff counts and e-liquid capacity, with the transparent tank as a key design highlight.
Jul.30 by 2FIRSTS.ai
World Vape Show Announcement: Due to customer product import issues, the Miami show in September has been postponed until further notice.
World Vape Show Announcement: Due to customer product import issues, the Miami show in September has been postponed until further notice.
World Vape Show Announcement: Due to difficulties with customer product imports, the Miami show originally scheduled for September 4-5, 2025, has been postponed until further notice.
Aug.20 by 2FIRSTS.ai
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
The U.S. Bankruptcy Court in New York has approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., granting legal effect in the U.S. to its participation in a CA$32.5 billion (US$23.6 billion) tobacco litigation settlement. The case is considered one of the largest corporate restructurings in Canadian history and also involves Japan Tobacco International (JTI), Philip Morris International (PMI), and British American Tobacco (BAT).
Aug.28 by 2FIRSTS.ai
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai